LEADER 02004nam a22003131a 4500
006 m o d f
007 cr bn mmmapmmp
008 130129s2011 xxu o f000 0 eng d
a| Library of Congress. b| Congressional Research Service. b| Resources, Science, and Industry Division.
a| Project BioShield h| [electronic resource] : b| Authorities, Appropriations, Acquisitions, and Issues for Congress.
a| [S.l] : b| [s.n.], c| 2011.
a| 1 online resource (21 p., digital, PDF file)
a| Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Jan. 2013). Reuse except for individual research requires license from ProQuest, LLC.
a| CRS Report.
a| Restricted for use by site license.
a| Provides overview of P.L. 108-276, the Project BioShield Act of 2004, which encourages private sector development of medical countermeasures such as diagnostic tests, drugs, vaccines, and other treatments, to respond to attacks using chemical, biological, radiological, and nuclear terrorism agents, and to provide a mechanism for Federal acquisition of those newly developed countermeasures. Covers appropriations, rescissions, and transfers; acquisitions; Biomedical Advanced Research and Development Authority oversight of Project BioShield activities; and policy issues.
a| System requirements: PDF reader software.
a| Medicine x| Research.
a| Public health.
a| Medical examinations.
a| ProQuest U.S. Congressional Research Digital Collection.
i| Microfiche version: a| Library of Congress. Congressional Research Service. Resources, Science, and Industry Division. t| Project BioShield
u| http://hdl.library.upenn.edu/1017.12/1731842 z| Connect to full text
a| UMI c| UMI
b| web h| -